Cargando…

Tauopathy Analysis in P301S Mouse Model of Alzheimer Disease Immunized with DNA and MVA Poxvirus-Based Vaccines Expressing Human Full-Length 4R2N or 3RC Tau Proteins

Alzheimer’s disease (AD) is a neurodegenerative disorder characterized by a progressive memory loss and cognitive decline that has been associated with an accumulation in the brain of intracellular neurofibrillary tangles (NFTs) formed by hyperphosphorylated tau protein, and extracellular senile pla...

Descripción completa

Detalles Bibliográficos
Autores principales:	García-Arriaza, Juan, Marín, María Q., Merchán-Rubira, Jesús, Mascaraque, Sara M., Medina, Miguel, Ávila, Jesús, Hernández, Félix, Esteban, Mariano
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7157204/ https://www.ncbi.nlm.nih.gov/pubmed/32183198 http://dx.doi.org/10.3390/vaccines8010127

Ejemplares similares

Phospho-Tau Accumulation and Structural Alterations of the Golgi Apparatus of Cortical Pyramidal Neurons in the P301S Tauopathy Mouse Model
por: Antón-Fernández, Alejandro, et al.
Publicado: (2017)

Alteration in the Synaptic and Extrasynaptic Organization of AMPA Receptors in the Hippocampus of P301S Tau Transgenic Mice
por: Alfaro-Ruiz, Rocio, et al.
Publicado: (2022)

Different modes of synaptic and extrasynaptic NMDA receptor alteration in the hippocampus of P301S tau transgenic mice
por: Alfaro‐Ruiz, Rocío, et al.
Publicado: (2022)

The Evolution of Poxvirus Vaccines
por: Sánchez-Sampedro, Lucas, et al.
Publicado: (2015)

Tau Spreading Mechanisms; Implications for Dysfunctional Tauopathies
por: Fuster-Matanzo, Almudena, et al.
Publicado: (2018)

p38 activation occurs mainly in microglia in the P301S Tauopathy mouse model
por: Perea, Juan R., et al.
Publicado: (2022)

Tauopathy-induced retinal dysfunction in the P301S mutant human tau transgenic mouse
por: Mazzaro, Nadia, et al.
Publicado: (2013)

The Role of Microglia in the Spread of Tau: Relevance for Tauopathies
por: Perea, Juan R., et al.
Publicado: (2018)

Differences Between Human and Murine Tau at the N-terminal End
por: Hernández, Félix, et al.
Publicado: (2020)

Humanized APOE genotypes influence lifespan independently of tau aggregation in the P301S mouse model of tauopathy
por: Williams, Tristan, et al.
Publicado: (2023)

RT-QuIC detection of tauopathies using full-length tau substrates
por: Tennant, Joanne M., et al.
Publicado: (2020)

Efficacy and Safety of A Liposome-Based Vaccine against Protein Tau, Assessed in Tau.P301L Mice That Model Tauopathy
por: Theunis, Clara, et al.
Publicado: (2013)

Poxvirus MVA Expressing SARS-CoV-2 S Protein Induces Robust Immunity and Protects Rhesus Macaques From SARS-CoV-2
por: Mooij, Petra, et al.
Publicado: (2022)

Dysfunction of the glutamatergic photoreceptor synapse in the P301S mouse model of tauopathy
por: Arouche-Delaperche, L., et al.
Publicado: (2023)

P301S Mutant Human Tau Transgenic Mice Manifest Early Symptoms of Human Tauopathies with Dementia and Altered Sensorimotor Gating
por: Takeuchi, Hiroki, et al.
Publicado: (2011)

Full efficacy and long-term immunogenicity induced by the SARS-CoV-2 vaccine candidate MVA-CoV2-S in mice
por: Lázaro-Frías, Adrián, et al.
Publicado: (2022)

Small molecule inhibitor of tau self-association in a mouse model of tauopathy: A preventive study in P301L tau JNPL3 mice
por: Davidowitz, Eliot J., et al.
Publicado: (2023)

Highly Attenuated Poxvirus-Based Vaccines Against Emerging Viral Diseases
por: Perdiguero, Beatriz, et al.
Publicado: (2023)

α-Lipoic acid improves abnormal behavior by mitigation of oxidative stress, inflammation, ferroptosis, and tauopathy in P301S Tau transgenic mice
por: Zhang, Yan-Hui, et al.
Publicado: (2017)

Deletion of Vaccinia Virus A40R Gene Improves the Immunogenicity of the HIV-1 Vaccine Candidate MVA-B
por: Pérez, Patricia, et al.
Publicado: (2020)

Optimized Hepatitis C Virus (HCV) E2 Glycoproteins and their Immunogenicity in Combination with MVA-HCV
por: Marín, María Q., et al.
Publicado: (2020)

Transcellular Spreading of Tau in Tauopathies
por: Demaegd, Koen, et al.
Publicado: (2018)

Enhancement of the HIV-1-Specific Immune Response Induced by an mRNA Vaccine through Boosting with a Poxvirus MVA Vector Expressing the Same Antigen
por: Gómez, Carmen Elena, et al.
Publicado: (2021)

Immunoproteomic analysis of a Chikungunya poxvirus-based vaccine reveals high HLA class II immunoprevalence
por: Lorente, Elena, et al.
Publicado: (2019)

Chronic Sleep Disruption Advances the Temporal Progression of Tauopathy in P301S Mutant Mice
por: Zhu, Yan, et al.
Publicado: (2018)

Removal of the C6 Vaccinia Virus Interferon-β Inhibitor in the Hepatitis C Vaccine Candidate MVA-HCV Elicited in Mice High Immunogenicity in Spite of Reduced Host Gene Expression
por: Q. Marín, María, et al.
Publicado: (2018)

Small-molecule modulation of the p75 neurotrophin receptor inhibits a wide range of tau molecular pathologies and their sequelae in P301S tauopathy mice
por: Yang, Tao, et al.
Publicado: (2020)

Are Tau Aggregates Toxic or Protective in Tauopathies?
por: Cowan, Catherine M., et al.
Publicado: (2013)

NMR Studies of Tau Protein in Tauopathies
por: Kitoka, Kristine, et al.
Publicado: (2021)

Immunogenic Profiling in Mice of a HIV/AIDS Vaccine Candidate (MVA-B) Expressing Four HIV-1 Antigens and Potentiation by Specific Gene Deletions
por: García-Arriaza, Juan, et al.
Publicado: (2010)

An MVA Vector Expressing HIV-1 Envelope under the Control of a Potent Vaccinia Virus Promoter as a Promising Strategy in HIV/AIDS Vaccine Design
por: Pérez, Patricia, et al.
Publicado: (2019)

Tau exon 10 alternative splicing and tauopathies
por: Liu, Fei, et al.
Publicado: (2008)

Glial Tau Pathology in Tauopathies: Functional Consequences
por: Kahlson, Martha A., et al.
Publicado: (2016)

Involvement of Oligodendrocytes in Tau Seeding and Spreading in Tauopathies
por: Ferrer, Isidro, et al.
Publicado: (2019)

Targeting tauopathy with engineered tau-degrading intrabodies
por: Gallardo, Gilbert, et al.
Publicado: (2019)

Phosphorylated Tau in Alzheimer’s Disease and Other Tauopathies
por: Rawat, Priyanka, et al.
Publicado: (2022)

In vivo functional brain mapping in a conditional mouse model of human tauopathy (tau(p301l)) reveals reduced neural activity in memory formation structures
por: Perez, Pablo D, et al.
Publicado: (2013)

Organotypic Brain Slice Cultures of Adult Transgenic P301S Mice—A Model for Tauopathy Studies
por: Mewes, Agneta, et al.
Publicado: (2012)

SWI and phase imaging reveal intracranial calcifications in the P301L mouse model of human tauopathy
por: Ni, Ruiqing, et al.
Publicado: (2020)

Towards a Mechanistic Model of Tau-Mediated Pathology in Tauopathies: What Can We Learn from Cell-Based In Vitro Assays?
por: Sala-Jarque, Julia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_o5gbs17gsv0ipdekvvslr644id